Lilly Reports First-Quarter 2023 Financial Results, Highlights Continued Core
Revenue in Q1 2023 decreased 11% driven by a $1.47 billion decline in revenue from COVID-19 antibodies. Excluding COVID-19 antibodies, revenue in Q1 2023 increased 10%, driven…
Read More...
Read More...